MSD and Eisai’s trial saw mixed success with its two primary endpoints, seeing success in progression-free survival, but ...

AM Best has affirmed the Financial Strength Rating of A+ (Superior) and the Long-Term Issuer Credit Rating of "aa-" (Superior) of Meiji Yasuda Life Insurance Company (Meiji Yasuda) (Japan). The ...

The Board of Directors of MVB Financial Corp. ("MVBF" or "MVB Financial") has announced the appointment of Glen W. Herrick as a Member of the Board. "MVB is pleased to have Glen join the MVB Board of ...

The trial builds off the company’s previous Phase Ia/II trial that saw an estimated survival rate of 52.4% at 24 months in ...